S&P 500 Rebounds Going into Fourth of July Holiday Weekend
The S&P 500 (Index: SPX) rebounded from the previous week’s heavy rotation away from AI and technology stocks, which had sent the index lower because several of these stocks happen to be among the biggest components of the capitalization weighted index. Altogether, the S&P rose by a little under 1.8% on the strength of their rebound, closing at 7,483.24 on Thursday, 2 July 2026 before traders and investors both headed out for the long Fourth of July holiday weekend.
Perhaps the most notable headlines driving stock prices during the week were those reporting about the declines of oil and fuel prices. The oil shock from the Iran war geopolitical event had raised fears of prolonged high inflation as the impact of high oil and gas prices would progressively spread into other sectors of the economy.
Falling oil and gas prices however would mitigate those inflationary pressures. That in turn would reduce the odds of multiple interest rate hikes by the Federal Reserve in upcoming months.
Overall, we find the S&P 500′s trajectory falls well within the new redzone forecast range we added to the alternative futures chart in the previous edition of this series:
This new redzone forecast range is based on the assumption investors will hold their forward-looking focus on the current quarter of 2026-Q3 as they set current day stock prices. That makes sense because the CME Group’s FedWatch Tool projects the Fed will hike the Federal Funds rate by a quarter point to a target range of 3.75-4.00% after the Fed meets on 16 September (2026-Q3).
The bigger question right now is what will happen beyond that date. Through the close of trading on 2 July 2026, the FedWatch tool anticipates another quarter point rate hike on 17 March (2027-Q1). But that expectation has been fluid over the last several weeks. If oil and fuel prices continue falling, we would expect the probability the Fed will hike rates in 2027 will drop below 50%. If oil and gas prices drop more quickly in the weeks ahead, then the expected rate hike in September 2026 will come into question.
That possibility, and other market moving events, will be something investors consider as weigh what they absorb the random onset of new information from the newstreams in those upcoming weeks. Speaking of which, here are the market moving headlines from the week that was:
- Monday, 29 June 2026
-
- Signs and portents for the U.S. economy:
- What’s good for the US economy now may not be good for stocks
- Cheaper AI is better: Soaring bills are reshaping how businesses choose models
- Oil settles up on US-Iran strikes; cautious hopes for shipping cap gains
- Fed minion with alleged ethics problems allowed to stay on job ‘for now’:
- Bigger trouble, stimulus developing in China:
- China’s factory activity likely returned to meagre growth in June: Reuters poll
- Rate On China’s New Overnight Liquidity Tool Comes Below Estimates, Hints At Imminent Easing
- China central bank conducts overnight reverse repos again, keeps rate at 1.25%, sources say
- China central bank doubles overnight cash injection, keeps rate unchanged, sources say
- ECB minions say Eurozone economy so good they can afford to hike rates:
- Wall Street closed higher as tech rebounded and U.S.-Iran tensions eased
- Tuesday, 30 June 2026
-
- Signs and portents for the U.S. economy:
- US single-family home prices ease on a monthly basis in April, FHFA says
- Oil falls as investors focus on potential Iran-US talks in Doha
- US retailers frontload China orders for holiday season, shipping firms say
- US job openings rise to two-year high, but hiring still struggling
- US expected to not extend USMCA, starting a decade-long countdown for trade pact
- Fed minions looking forward to some peace and quiet, still fear inflation and are starting to lose some of their best customers:
- Quarter-end expected to be quiet for Fed liquidity facilities
- Fed’s Hammack tells CNBC rate hikes may be needed to quell high inflation
- For first time, more central banks are set to shrink dollar holdings, survey finds
- Some growth signs developing in China:
- Bigger trouble developing in Japan, BOJ minions credibility again at risk:
- Japan’s May factory output growth lagged forecasts
- BOJ’s slow, dovish revamp casts doubt over long-term rate-hike plans
- ECB minions suddenly rethinking their rate hike plans for Eurozone, still afraid of inflation:
- ECB should not rush any further rate hike, Demarco says
- Lower oil price eases pressure on ECB to act, Dolenc says
- ECB’s inflation fears linger despite oil price retreat
- S&P 500, Nasdaq register best quarter since 2020 despite Iran war
- Wednesday, 1 July 2026
-
- Signs and portents for the U.S. economy:
- Oil falls as markets await outcome of Iran-US talks, US stocks data
- New chief Fed minion lays out the central bank’s agenda for Fed minions:
- Fed’s Warsh vows to ‘disappoint’ anyone who thinks he will tolerate inflation above 2%
- Fed’s Warsh plans to harness better economic data within a year
- Fed’s Warsh says any balance sheet policy change won’t be a surprise
- Mixed growth signs developing in China:
- China resale home prices fall faster in June, shows private survey
- China’s factory activity completes strongest quarter since late 2020, private PMI shows
- Japan’s economy shows signs of growth, BOJ minions salivate over opportunity to hike Japan’s interest rates:
- ECB minions plans to keep hiking rates may be put on hold:
- U.S. stocks decline at the start of the second half of the year as tech struggles
- Thursday, 2 July 2026
-
- Signs and portents for the U.S. economy:
- US job growth likely cooled in June after recent string of big gains
- 2-year Treasury yield eases as light jobs report reduces Fed hike expectations
- US factory orders fall in May, weighed down by weak demand for commercial aircraft
- Oil falls for a third straight day after US, Iran conclude talks in Doha
- Why the U.S. housing shortage might be nearing its end
- Odds of rate hike before year-end fall; odds for one 25 bps cut rise
- Fed minions thinking about maybe not hiking U.S. interest rates, say their current monetary policies are ‘slightly restrictive’:
- Cooling US jobs data buys the Fed and stock market more time
- Weak jobs, declining labor force, could renew Fed debate over state of labor market
- Fed’s Daly says US policy ‘slightly restrictive,’ next step uncertain
- Bigger trouble, stimulus developing in China:
- BOJ minions / Bigger trouble developing in Japan:
- ECB minions want to keep tight control over Eurozone banks to keep them from risk of failure, even if it means losing money:
- ECB considers lifting banks’ minimum reserves to lessen own losses
- S&P 500 posts weekly gain, led by financials and communication services
The Atlanta Fed’s GDPNow tool‘s estimate of real GDP growth for the U.S. economy in the current quarter of 2026-Q2 plunged to +1.2% from the previous week’s real growth estimate of +2.5%.
Image credit: Microsoft Copilot Designer. Prompt: “An editorial cartoon of a Wall Street bull and bear watching a Fourth of July drone show”.
Source: https://politicalcalculations.blogspot.com/2026/07/s-500-rebounds-going-into-fourth-of.html
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.



